Aastrom Biosciences, Inc (ASTM)
Contact Information:
| Business Address: | - |
| Mailing Address: | Business Address 24 FRANKL LLOYD WRIGHT DR PO BOX 376 ANN ARBOR MI 48106 7349305555 AASTROM BIOSCIENCES INC CIK #: 0000887359 (see all company filings) SIC : 2 |
| Phone: | 734-930-5555 |
| Fax: | 734-665-0485 |
| Website: | http://www.aastrom.com |
Company Details:
| Symbol: | ASTM |
| SIC: | - |
| State location: | MI |
| Sector: | - |
| State of Inc: | MI |
| Employees: | 45 |
| Type: | NASDAQ |
Key executives:
| Name | Age | Position |
|---|---|---|
| Alan M. Wright | 67 | Consultant |
| George W. Dunbar Jr. | 65 | Chief Exec. Officer, Pres |
| Gerald D. Brennan Jr., J.D. | 61 | Chief Financial Officer, Principal Accounting Officer, VP of Admin. & Financial Operations, Sec. and Treasurer |
| Janet M. Hock B.D.S., Ph.D. | 68 | Chief Scientific Officer and VP of Global Research |
| Robert J. Bard J.D. | 60 | VP of Regulatory Affairs and Quality Systems |
(ASTM, CMTL) Market Watch For Thursday, December 16, 2010 From... Dec 15, 2010, 17:57
Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading developer of expanded autologous cellular therapies for the treatment of severe, chronic cardiovascular diseases, announced that it has completed a public offering of 10,000,000 units at a price to the public of $2.25 per unit for an aggregate offering amount of $22.5 million, as previously announced on December 10, 2010. The net proceeds to Aastrom, after underwriting discounts and commissions read more
| Promoter: pennyomega.com | Paying Party: No Third Party | Max Profit: Pending | Gain at close: Pending |
| Stock: ASTM | Compensation: Unknown compensation | Avg $ Volume for Period: UNKNOWN | |
| Stock: CMTL | Compensation: Unknown compensation | Avg $ Volume for Period: UNKNOWN | |
| Post # | Subject | Re | Name | Date |
|---|---|---|---|---|
| 1 | Have you noticed this company's stock... | 0 | Jillene | May 01, 2008, 02:05AM |
| 2 | Here on this message board we are inviting... | 0 | Guest | May 01, 2008, 02:05AM |

